Literature DB >> 8796143

Identification of a novel mutation in hereditary vitamin D resistant rickets causing exon skipping.

N S Hawa1, F J Cockerill, S Vadher, M Hewison, A R Rut, J W Pike, J L O'Riordan, S M Farrow.   

Abstract

OBJECTIVE: Hereditary vitamin D resistant rickets (HVDRR) is an autosomal recessive disorder resulting in target organ resistance to the actions of 1,25-dihydroxyvitamin D3 (1,25(OH)2D3). In many cases, this disorder has been shown to be due to mutations in the gene encoding vitamin D receptors (VDR). In a patient with characteristic features of this disorder, we investigated the functional defect and sequenced the coding region of the gene for mutations.
DESIGN: Skin fibroblasts from patient and control were used to measure binding of 1,25(OH)2D3 and functional responses to the hormone. These cells were also used to prepare RNA from which cDNA was prepared and sequenced. Furthermore, genomic DNA was prepared from the fibroblasts and the intron/exon boundaries sequenced. PATIENT: A child with classic features of HVDRR with alopecia diagnosed as having rickets due to resistance to 1,25(OH)2D3. MEASUREMENTS: Nuclear association of 1,25(OH)2D3 was determined in patient and control cells and the functional response to 1,25(OH)2D3 was assessed by measurement of 25-hydroxyvitamin D-24-hydroxylase(24-hydroxylase) activity. VDR cDNA and genomic DNA prepared from patient and control cells were sequenced.
RESULTS: Cells from the patient with HVDRR had undetectable amounts of VDR compared to control cells and did not show induction of 24-hydroxylase activity following treatment with 1,25(OH)2D3. Sequencing of the VDR coding region after RT-PCR of RNA revealed an absence of exon 4 in patient RNA which was not due to a deletion in genomic DNA but was caused by exon skipping during RNA processing. In addition, the deletion of exon 4 sequences from RNA leads to a frameshift in translation resulting in a premature stop codon. Amplification of genomic DNA around the intron/exon boundary of exon 4 revealed a point mutation in the 5' donor splice site of intron 4.
CONCLUSION: In this study, we have identified a novel mutation in the gene for vitamin D receptors in a patient with the characteristic phenotype of hereditary vitamin D resistant rickets. The mutation at the +5 position in intron 4 is most likely to cause skipping of exon 4 in this patient.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8796143

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  7 in total

Review 1.  Genetic disorders and defects in vitamin d action.

Authors:  Peter J Malloy; David Feldman
Journal:  Endocrinol Metab Clin North Am       Date:  2010-06       Impact factor: 4.741

Review 2.  Mutations in the vitamin D receptor and hereditary vitamin D-resistant rickets.

Authors:  David Feldman; Peter J Malloy
Journal:  Bonekey Rep       Date:  2014-03-05

3.  A unique insertion/duplication in the VDR gene that truncates the VDR causing hereditary 1,25-dihydroxyvitamin D-resistant rickets without alopecia.

Authors:  Peter J Malloy; Jining Wang; Lihong Peng; Sunil Nayak; Jeanne M Sisk; Catherine C Thompson; David Feldman
Journal:  Arch Biochem Biophys       Date:  2006-10-16       Impact factor: 4.013

4.  Vitamin D receptor mutations in patients with hereditary 1,25-dihydroxyvitamin D-resistant rickets.

Authors:  Peter J Malloy; Velibor Tasic; Doris Taha; Filiz Tütüncüler; Goh Siok Ying; Loke Kah Yin; Jining Wang; David Feldman
Journal:  Mol Genet Metab       Date:  2013-11-04       Impact factor: 4.797

5.  Hereditary vitamin D resistant rickets: identification of a novel splice site mutation in the vitamin D receptor gene and successful treatment with oral calcium therapy.

Authors:  Nina S Ma; Peter J Malloy; Pisit Pitukcheewanont; Daina Dreimane; Mitchell E Geffner; David Feldman
Journal:  Bone       Date:  2009-06-10       Impact factor: 4.398

Review 6.  Insights into genetic and epigenetic determinants with impact on vitamin d signaling and cancer association studies: the case of thyroid cancer.

Authors:  Grégoire B Morand; Sabrina Daniela da Silva; Michael P Hier; Moulay A Alaoui-Jamali
Journal:  Front Oncol       Date:  2014-11-04       Impact factor: 6.244

7.  The frequency of clinical manifestations of hypophosphatemic rickets in patients with therapeutic strategies.

Authors:  Leila Kanafi Vahed; Afshin Arianpur; Mohammad Esmaeili
Journal:  Clin Pract       Date:  2018-05-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.